New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics.

Are you battling mounting debts with no end in sight? Feeling overwhelmed by payments you can barely afford? You’re not alone ...

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...